Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(CLNO, CSTR, PWRM, INTU, NTAP) Stock in Action by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

http://pennyomega.com/img/clno.jpg Cleantech Transit Inc. (OTCPK:CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (
www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

Cleantech Transit, Inc. is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction approximately June 30th. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

"This is a significant milestone for the Company and our goal is to continue to build value as we progress," said Mr. Kenneth Bosket, Cleantech's President and CEO.

The use of biomass can help reduce Global Warming. Plants use and store carbon dioxide (CO2) when they grow. When it burns or decomposes, it releases the CO2. Replanting plants, crops or trees etc. ensures that the C02 is reused. If the plants are not replanted the biomass will disrupt the natural carbon equilibrium and thus continue to contribute towards Global Warming.

Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.

******************

Coinstar, Inc. (NASDAQ:CSTR), announced the appointment of Maria D. Stipp as its chief customer officer. Stipp joins Coinstar with more than 20 years experience in sales and senior management roles in the video game industry and consumer packaged goods. Most recently, Stipp served as the executive vice president and general manager of the Owned Properties Global Business Unit at Activision.

Coinstar, Inc.is a leading provider of automated retail solutions offering convenient services that make life easier for consumers and drive incremental traffic and revenue for retailers. For more information, visit
www.coinstarinc.com.

******************

power3 Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Nerve cells use a brain chemical called dopamine to help control muscle movement. Parkinson's disease occurs when the nerve cells in the brain that make dopamine are slowly destroyed. Without dopamine, the nerve cells in that part of the brain cannot properly send messages. This leads to the loss of muscle function. The damage gets worse with time. Parkinson's in children may occur because the nerves are not as sensitive to dopamine. Parkinson's is rare in children.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

********************

Intuit Inc. (Nasdaq:INTU) announced it has acquired mobile Web banking technology assets from Mobile Money Ventures, or MMV, a leading global provider of next-generation mobile financial solutions. This transaction bolsters Intuit Financial Services' position as a leading online and mobile technology provider to financial institutions. Intuit will be able to directly manage customer support and will have full control over the design of its mobile Web banking solutions. The acquired assets will also help the company bring new innovations to financial institution customers faster.

Intuit Inc. is a leading provider of business and financial management solutions for small and mid-sized businesses; financial institutions, including banks and credit unions; consumers and accounting professionals.More information can be found at
www.intuit.com.

********************

NetApp, Inc. (NASDAQ:NTAP) announced that it intends to repurchase an aggregate of $200 million of its common stock under its preexisting stock repurchase program, beginning in July 2011. After the completion of this transaction, $900 million will remain in the preexisting authorization. NetApp will, from time to time, purchase shares of common stock, subject to prevailing market conditions, in open market or privately negotiated transactions.

NetApp creates innovative storage and data management solutions that deliver outstanding cost efficiency and accelerate business breakthroughs. Discover our passion for helping companies around the world go further, faster at
www.netapp.com.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg